language.en-US
  • EN
  • RU
Modified short treatment for rifampicin-resistant tuberculosis

1st webinar of the Virtual Medical Consilium (VMC), held on October 7, 2020

Webinar program:

- Greetings. Brief overview of the implementation of the Regional Operational Research on Modified Shorter Treatment Regimens for RR-TB in the WHO European Region. Dr. Askar Yedilbaev and Alexander Korotych, Department of Tuberculosis, Joint Program on Tuberculosis, HIV and Viral Hepatitis, Country Health Programs Unit

- Virtual Medical Consilium: tasks, functioning, making a request. Dr. Elmira Gurbanova, VMC Coordinator;

- The choice of treatment regimen and specifities of prescribing mSTR to patients , Dr. Gunta Dravniece, member of the VMC;

- Physician-patient interaction: informed consent and communication. Dr. Liga Kuksha, member of the VMC;

- Questions and answers.

The video record of this webinar is available on Russian only

1. Update on mSTR_ENG.pdf 2. Virtual medical Consilium on mSTR_ENG.pdf 3. Selection of DR-TB regimen_mSTRs enrollment_WHO_ENG.pdf 4. Informed Consent mSTRs L.Kuksa WHO_ENG.pdf 1. Update on mSTR_RUS.pdf 2. Virtual medical Consilium on mSTR_RUS.pdf 3. Selection of DR-TB regimen_mSTRs enrollment_WHO_RUS.pdf 4. Informed Consent mSTRs L.Kuksa WHO_RUS.pdf Guidelines for submitting requests to the VMC_v3.pdf Инструкция по оформлению запроса в ВМК_v3.pdf Case_Submission_Form_v2 .doc Форма представления случая на консилиум ВМК_v2.doc